Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03347383

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
  • ID3 Medical Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03347383
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03347383. Allocation not applicable; no masking; primary purpose treatment. Start 2017-09-19 (actual); primary completion 2019-10-16 (actual). Results posted on 2025-03-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions
Acronym
TINTIN
Condition
Peripheral Arterial Disease
Intervention (Device)
Combination therapy DCB + stent
Lead sponsor
ID3 Medical (class: other)

Record details

Record id
cardio:ct-nct03347383
Content hash
59643a4c3c11fce08bd0663d64a1a2ad4e85341848a1d6b1ddec0e182c4ddf0f